-
04-09-2014, 12:16 PM
#9211
This company keeps ticking the boxes one by one and I'm proud to be one of its long term shareholders
-
04-09-2014, 12:20 PM
#9212
Was obtaining this patent unlikely?
But whatever, we will take the extra excitement it seems to have created.
Perhaps Mr Market now sees PEB may not be just a one trick pony?
-
04-09-2014, 12:20 PM
#9213
Member
-
04-09-2014, 12:30 PM
#9214
Originally Posted by sharp
So am I. I might get in some more
How much is such a patent in worth?
When it becomes commercialised its worth lot’s as far as I’m concerned as a skin cancer patient, if it means through better prognosis that aggressive cancers can be better assessed then it’s less likely that the docs will take a ‘chop it off and ask biopsy questions later’ approach. You would be astonished at how easy they pull the scalpels out when in doubt, its scary stuff when you start losing bits and pieces.
-
04-09-2014, 12:34 PM
#9215
Originally Posted by stoploss
Maybe a quick lift to 90 .....
No no - wont stop there $1.10 looks a good place on the squigqly line thingie
-
04-09-2014, 12:34 PM
#9216
Member
The American Cancer Society estimates that at present, more than 120,000 new cases of melanoma in the US are diagnosed in a year. In 2014, an estimated 76,100 of these will be invasive melanomas, with about 43,890 in males and 32,210 in women.
Last edited by hilskin; 04-09-2014 at 12:37 PM.
-
04-09-2014, 12:39 PM
#9217
Member
Cetrainly a good indication that things are on track. Aside from the melanoma patent, the confirmation that the triage and prediction technology are nearing comercialisation is very positive. Also, it's not the first time in recent weeks that they have said they are looking at targeting other international markets. Obviously some talks going on. My guess would be something out of Singapore.
-
04-09-2014, 01:00 PM
#9218
Clinical trials and regulatory approvals next, let’s say that takes 18 to 24 months. Should be all good and ready to phase into the market with all that cash the Cxbladder cash cow is intended to provide.
Cxbladder product suite this year into next, then Cxcolorectal than shall we call it Cxmelanoma, nice, just like a sausage machine.
Attachment 6218
Last edited by MAC; 04-09-2014 at 01:02 PM.
-
04-09-2014, 01:20 PM
#9219
Originally Posted by NewGuy
the patent itself carries significant value IMHO, so this news represents a significant uplift in PEB's overall value proposition.
When quality stocks like PEB with good fundamentals are so grossly undervalued all catalysts will lift the boat.
Agree though, patients add to the value proposition of products, make it more difficult for competitors to enter, and it's likely should a takeover be contemplated downstream that the patent suite will be priced.
-
04-09-2014, 01:31 PM
#9220
2nd Sept 2014
Originally Posted by Hoop
Do you think PEB will revisit Sub 70?.......PEB chart is the best it has looked since March....The double bottom pattern seems confirmed when 75c bull/bear line was cracked.....A bit early yet to be sure (still could get a confirmation failure)..but at the moment the Bear cycle looks to be done and dusted
see my todays chart below
Originally Posted by klid
Trading halt???.......
Melanoma? Where did that come from!? Hah, fantastic.
......85/56 not looking so strong now
EDIT: 86 sell restacked - it is resistance right? I ain't no TAer but I think that's the case?
Not much resistance chartwise at 86..
A little more resistance at 91 (drawn on chart)
The main resistances are the 98 - 101 area..the 110 area ...and 120, the old scary cliff face that represented the last line of support before breaking into the vacuum a few months back.
Disc: hold ( IN were my buy points)
Last edited by Hoop; 04-09-2014 at 01:40 PM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks